We present a microfluidic tilting platform with gravity-driven flow that enables culturing of three-dimensional microtissues under in vivo-like drug dosing regimens. In contrast to traditional, constant dosing regimens, the chip allows for gradual changes in substance concentrations. Dosing gradients are generated through an asymmetric Y-junction of microfluidic channels of different widths. Changes in the chip operation parameters, e.g., different tilting angles, enable to alter the drug dosage on demand. The concentration changes over time matched the predicted values, and preformed microtissues could be cultured in the chip system for at least 24 h. The chip represents an easy-to-handle tool for toxicity and efficacy testing of transient drug concentrations changes.
Introduction
During the last decades, screening methods for efficacy and toxicity of drugs moved away from animal models towards human in vitro cell culture models [1] . This paradigm change offers the potential to better predict the impact of drugs on the human body when using adequate cell culture models. Especially sophisticated 3D in vitro tissue models, e.g., organotypic multicellular microtissues (MTs), organoids or ex vivo organs, closely reproduce tissue morphology and functionality, and the mechanical properties and biochemical environment of native 3D phenotypes of living organs [2] .
In vitro toxicity studies routinely include constant compound dosage over a defined time. These profiles, however, do not represent the in vivo situation. Upon repeated uptake of certain substances, their concentration in the human body gradually increases until a steady state is reached (Figure 1 ). Simplified protocols often lead to false positive results during toxicity and efficacy testing [3] . To realize physiologically relevant conditions in vitro, multiple pipetting steps or experimental setups with complex pumping schemes are applied to date (Figure 1 ). Recently, we presented a tubing-free microfluidic platform using gravity-driven flow perfusion through platform tilting [4] . The platform allows for robust and parallelized culturing of multiple, interconnected microtissues and for observing their reactions upon exposure to compounds. Here, we modified our existing chip system to enable variable dosage protocols. The chip features three liquid reservoirs, two of which are located on the same side. Both are connected to the main channel trough differently sized channels (Figure 2a) . Upon filling the two reservoirs on the left side with cell culture medium (wide channel) and a treatment solution (narrow channel), the liquids combine in the asymmetric Y-junction and then pass a mixing structure before reaching the MTs. Barrier structures in the spheroid compartments partially surround the introduced MTs (Figure 2b ,c) to protect them against direct exposure to medium flow and resulting shear stress. A computational fluid dynamics simulation (COMSOL Multiphysics, Figure 2d ) was used to show this effect. With every tilting cycle, more of the treatment substance is released into the system so that the concentration gradually increases (Figure 3a) , until an equilibrium in the main channel is reached. 
Methods

Fabrication
The device was fabricated in PDMS using a SU-8 bottom mold and a PDMS top mold. For the SU-8 mold, previously reported microfabrication processes with two layers were used [4] . The first 100-μm-thick layer includes the channel structures and MT compartments with their barriers. The herringbone structures for efficient mixing of the two liquids (25 μm in height) were designed as recommended by Stroock, et al. [5] .
The top mold includes all surface structures (reservoirs and MT loading ports). A 3D-printed template (Accura 3350, Proto Labs, Germany) was used to cast the PDMS top mold. Treatment with trichlorosilane prevented the fusion of the top mold with the final chip and enabled multiple usage of the mold.
The casted PDMS chips were O2-plasma-bonded to standard microscopic glass slides to close the channels. All channels, reservoirs and MT compartments were then coated with Biolipidure 206 to render them hydrophilic and to prevent MTs from attaching to the surfaces.
Device Operation
Channels and reservoirs were initially flooded with cell culture medium. Next, preformed spherical MTs were harvested from a microplate with a pipette and transferred to their designated compartments.
In vivo-like treatment was initiated by filling the reservoirs on the side of the Y-junction with plain medium (wide channel) and medium containing a substance of interest (narrow channel). Repetitive tilting by an angle α induced a controlled concentration increase of the substance in the main channel and the MT compartments. The concentration changes by the unequal volumes of liquid flowing from the two reservoirs into the common channel during one tilting interval. Upon flowing backwards to the Y-junction, the liquid is assumed to split up at the same ratio at which it entered the main channel (Figure 3a) . By changing the tilting angle α, the dosing can be modulated. At larger angles, a higher flow rate is achieved, which results in faster mixing of the two solutions and a steeper concentration curve. The opposite holds true for smaller angles with lower flow rates and comparably flat curves.
The entire experimental setup including a GravityFLOW™ tilting device (InSphero AG, Switzerland) and a humidity chamber, harboring the chips, can be operated in a cell culture incubator at standard mammalian cell culture conditions (37 °C, 5% CO2, 95% humidity). Stackable humidity chambers hold up to 4 chips, which enables higher throughput and parallelized operation.
Assessment of Concentration Changes
Based on the channel dimensions, their hydrostatic resistances and the resulting flow rates the tilting-dependent changes of concentrations in the main channel were calculated. The changes were tracked using amaranth red in H2O in the dosing reservoir with the narrow channel and plain H2O in the wide channel. After every tilting cycle, the absorbance of the liquid in the shared reservoir was measured at a wavelength of 520 nm in reference to the loading solution using a NanoDrop2000 (ThermoScientific, Switzerland).
Microtissue Analyses
To track changes of the MTs upon substance exposure, morphology and size, as well as secreted albumin and intracellular ATP were measured.
Results and Discussion
For concentration measurements over time, tilting angles of 20° and 40° were chosen to demonstrate the modulation of the dosing curve. The measurements evidenced a good correlation to calculated values for both tilting angles and demonstrated that gradual concentration changes could be predicted and achieved (Figure 3b ). The modulation of the tilting angle changed the slope of the dosing curve, allowing to mimic curves that resemble the pharmacokinetics of common substances.
We also assessed the performance of previously formed human liver microtissues (hLiMT, InSphero AG, Switzerland) in the device. The MTs were cultured for 24 h in human liver maintenance medium (hLiMM, InSphero AG, Switzerland) and compared to static well-plate-cultured spheroids using standard mammalian cell culture conditions. Images of the microtissues (Figure 4c ) did not show significant differences between static and perfused culturing conditions and confirmed that the spheroids preserve their compact morphology even under flow and light shear stress. Assessment of microtissue viability (Figure 4a ) according to intracellular ATP concentrations (CellTiterGlo 3D Cell Viability Assay, Promega, Switzerland) showed similar average values for culturing that was performed under perfusion and static control conditions. Detection of secreted albumin (Albumin ELISA Kit, Bethyl Laboratories, Inc., Montgomery, TX, USA; Figure 4b ), a liver specific marker, in the supernatant of both conditions showed higher secretion rates for hLiMT cultured under perfusion on chip. The increased microtissue functionality, shown by albumin secretion, in combination with their similar viability demonstrate the advantages of using perfused in vitro systems in comparison to standard static cell culture conditions. 
Conclusions and Outlook
In this paper, an easy-to-use in vitro method for the exposure of 3D microtissues to continuously varying concentrations of a substance of interest was presented. By using the proposed channel structures on a tilting device, gradually increasing concentrations to mimic physiological, in vivolike concentration changes upon drug dosing could be achieved without the need for time-consuming pipetting schemes or sophisticated pumping protocols.
We showed the culturing of a sensitive cell type, hLiMTs, in the device, which demonstrates the potential of the device for many other 3D cell culture models. The combination of different, organspecific microtissues and their interplay can be monitored in the presented setup, e.g., by combining liver and cancer microtissues so that efficacy and toxicity of cancer treatments could be simultaneously evaluated.
